Efficacy and Safety of Xinyi Powder in Patients With Allergic Rhinitis and the Lung Deficiency and Cold Syndrome | MicrobiomeTrials← Back to trialsNCT07899515
Efficacy and Safety of Xinyi Powder in Patients With Allergic Rhinitis and the Lung Deficiency and Cold Syndrome
TERMINATEDNAINTERVENTIONAL
Trial Details
Start: 2024-10-23Est. Completion: 2026-07-25
Enrollment target: 228 participants Locations- Jiangsu Provincial Second Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, China
- Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Other microbiome trials you might be interested in
AsthmaAsthma in ChildrenAllergyRhinitis, AllergicAtopic DermatitisAllergen Immunotherapy
The summary is available at --\> https://www.finnatopy.fi/summary
Tampere, FinlandCompleted Dec 2032
Perennial Allergic Rhinitis (PAR)
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perenni…
Huntington Beach, United StatesEst. completion Oct 22, 2026